Market closedNon-fractional
Xtant Medical/XTNT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Xtant Medical
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
Ticker
XTNT
Sector
Healthcare
Trading on
AMEX
Industry
Health Care Equipment and Supplies
Headquarters
Belgrade, United States
Employees
211
Website
www.xtantmedical.com
Xtant Medical Metrics
BasicAdvanced
$95M
Market cap
-
P/E ratio
-$0.01
EPS
0.33
Beta
-
Dividend rate
Price and volume
Market cap
$95M
Beta
0.33
Financial strength
Current ratio
2.34
Quick ratio
0.915
Long term debt to equity
36.848
Total debt to equity
60.315
Interest coverage (TTM)
-3.77%
Management effectiveness
Return on assets (TTM)
-9.58%
Return on equity (TTM)
-4.13%
Valuation
Price to revenue (TTM)
0.895
Price to book
1.99
Price to tangible book (TTM)
3.09
Price to free cash flow (TTM)
-6.121
Growth
Revenue change (TTM)
60.81%
Earnings per share change (TTM)
-84.08%
3-year revenue growth (CAGR)
25.59%
3-year earnings per share growth (CAGR)
-49.25%
What the Analysts think about Xtant Medical
Analyst Ratings
Majority rating from 2 analysts.
Xtant Medical Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$28M
-1.07%
Net income
-$4.4M
2.33%
Profit margin
-15.82%
3.40%
Xtant Medical Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.02
$0.07
-$0.03
-$0.03
-
Expected
-$0.02
-$0.02
-$0.03
-$0.02
-$0.02
Surprise
0.00%
-450.00%
20.00%
100.00%
-
Xtant Medical News
AllArticlesVideos
Xtant Medical to Present at the Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase
Accesswire·2 days ago
Xtant Medical Holdings, Inc. (XTNT) Q1 2024 Earnings Call Transcript
Seeking Alpha·2 months ago
Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024
Accesswire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Xtant Medical stock?
Xtant Medical (XTNT) has a market cap of $95M as of July 27, 2024.
What is the P/E ratio for Xtant Medical stock?
The price to earnings (P/E) ratio for Xtant Medical (XTNT) stock is 0 as of July 27, 2024.
Does Xtant Medical stock pay dividends?
No, Xtant Medical (XTNT) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Xtant Medical dividend payment date?
Xtant Medical (XTNT) stock does not pay dividends to its shareholders.
What is the beta indicator for Xtant Medical?
Xtant Medical (XTNT) has a beta rating of 0.33. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Xtant Medical stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.